(Q50856021)

24 March 2018

title

Prognosis of chronic hepatitis C: results of a large, prospective cohort study. (English)

1 reference

24 March 2018

1 reference

1 reference

1 reference

Niederau C

1

1 reference

24 March 2018

Lange S

2

1 reference

24 March 2018

Heintges T

3

1 reference

24 March 2018

Erhardt A

4

1 reference

24 March 2018

Buschkamp M

5

1 reference

24 March 2018

Hürter D

6

1 reference

24 March 2018

Nawrocki M

7

1 reference

24 March 2018

Kruska L

8

1 reference

24 March 2018

Hensel F

9

1 reference

24 March 2018

Petry W

10

1 reference

24 March 2018

Häussinger D

11

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

24 March 2018

published in

Hepatology

1 reference

24 March 2018

volume

28

1 reference

24 March 2018

page(s)

1687-1695

1 reference

24 March 2018

issue

6

1 reference

24 March 2018

Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

The long-term pathological evolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

The natural history of chronic hepatitis C and what we should do about it

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi-institution analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Severity of liver disease with different hepatitis C viral clones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

HCV genotypes in patients with liver disease of different stages and severity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Hepatitis C and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

HCV-associated liver cancer without cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: clinical study of 26 cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Hepatitis C virus genotypes and development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280632

7 January 2021

Identifiers

DOI

10.1002/HEP.510280632

1 reference

24 March 2018

PubMed ID

9828236

1 reference

24 March 2018